Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computational engineering of previously crystallized pyruvate formate-lyase activating enzyme reveals insights into SAM binding and reductive cleavage. | J Biol Chem | 2023 | 37156396 | PubTator, text mining | PubMed |
| New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance. | Front Immunol | 2023 | 37153591 | PubTator, text mining | PubMed |
| Interaction gene set between osteoclasts and regulatory CD4+ T cells can accurately predict the prognosis of patients with osteosarcoma. | Cancer Sci | 2023 | 37150900 | PubTator, text mining | PubMed |
| NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma. | BMC Urol | 2023 | 37138262 | PubTator, text mining | PubMed |
| Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma. | Channels (Austin) | 2023 | 37134043 | PubTator, text mining | PubMed |
| Cutaneous lesions in psoriatic arthritis are enriched in chemokine transcriptomic pathways. | Arthritis Res Ther | 2023 | 37131254 | PubTator, text mining | PubMed |
| Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma. | Front Immunol | 2023 | 37122750 | PubTator, text mining | PubMed |
| PPAR-γ regulates the effector function of human T helper 9 cells by promoting glycolysis. | Nat Commun | 2023 | 37120582 | PubTator, text mining | PubMed |
| STAT2 act a prognostic biomarker and associated with immune infiltration in kidney renal clear cell carcinoma. | Medicine (Baltimore) | 2023 | 37115061 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting. | Int J Mol Sci | 2023 | 37108657 | PubTator, text mining | PubMed |
| Dynamic chromatin accessibility licenses STAT5- and STAT6-dependent innate-like function of TH9 cells to promote allergic inflammation. | Nat Immunol | 2023 | 37106040 | PubTator, text mining | PubMed |
| A Novel Prognostic Biomarker CCR8 for Gastric Cancer and Anti-CCR8 Blockade Attenuate the Immunosuppressive Capacity of Tregs In Vitro. | Cancer Biother Radiopharm | 2023 | 37102694 | PubTator, text mining | PubMed |
| Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2023 | 37101765 | PubTator, text mining | PubMed |
| Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. | Oncoimmunology | 2023 | 37089449 | PubTator, text mining | PubMed |
| Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer. | BMC Gastroenterol | 2023 | 37081402 | PubTator, text mining | PubMed |
| FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37074800 | PubTator, text mining | PubMed |
| Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers. | Mol Cancer | 2023 | 37072770 | PubTator, text mining | PubMed |
| Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective. | Front Oncol | 2023 | 37064113 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals CCDC60 as a potential biomarker correlated with prognosis and immune infiltration of head and neck squamous cell carcinoma. | Front Oncol | 2023 | 37064086 | PubTator, text mining | PubMed |
| Cytokine concentration in peripheral blood of patients with colorectal cancer. | Front Immunol | 2023 | 37063892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=16